Related Experiment Videos
Inducing cancer cell death by targeting transcription factors
Ryungsa Kim1, Kazuaki Tanabe, Manabu Emi
1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. rkim@hiroshima-u.ac.jp
Abstract:
We review the biological significance of transcription factors such as p53, Myc, E2F family and AP-1 (Jun/Fos) in anticancer drug-induced apoptosis. It is likely that the functional role of these transcription factors is complex in response to DNA damage depending on cancer cell type. Regulation of apoptosis following DNA damage is mediated by cell cycle arrest for DNA repair and subsequent signal transduction pathways leading to apoptosis, which is associated with mitochondrial dysfunction. Activation of transcription factors following anticancer drugs is located upstream of signal transduction pathways, thereby the downstream pathway is promoted, which is connected to activation or suppression of apoptosis-related proteins. Switching on apoptotic signals by anticancer drugs is amplified in mitochondria by releasing cytochrome from the ion channel to activate the caspase cascade, which is regulated by Bcl-2 families in the central gate for drug-induced apoptosis. Activation of transcription factors targeting downstream genes, some of which are apoptosis-related genes, can play a critical role in promoting apoptosis following treatment with anticancer drugs. The strategy of identification of downstream target proteins or transcription factors involved in apoptosis will be necessary for the development of an effective transcription factor-targeted chemotherapy for cancer.
Insights
Transcription factors like p53 play a complex role in cancer drug-induced apoptosis. Understanding these factors is key to developing targeted cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Transcription factors, including p53, Myc, E2F family, and AP-1 (Jun/Fos), are crucial in cellular responses to DNA damage.
- Anticancer drug efficacy is often linked to their ability to induce apoptosis, a programmed cell death pathway.
- The precise role of transcription factors in drug-induced apoptosis varies significantly with cancer cell type and DNA damage context.
Purpose of the Study:
- To review the biological significance of key transcription factors in anticancer drug-induced apoptosis.
- To elucidate the complex regulatory mechanisms involving transcription factors, cell cycle arrest, and mitochondrial pathways in apoptosis.
- To highlight the potential of targeting transcription factors for developing novel cancer chemotherapies.
Main Methods:
- Literature review of studies investigating transcription factor roles in apoptosis.
- Analysis of signaling pathways, including cell cycle regulation, DNA repair, and mitochondrial dysfunction.
- Examination of the interplay between transcription factors and apoptosis-related proteins, such as Bcl-2 family members and caspases.
Main Results:
- Transcription factor activation by anticancer drugs precedes downstream signaling, influencing apoptosis-related protein expression.
- Mitochondrial pathways, involving cytochrome release and caspase activation, are critical for amplifying apoptotic signals.
- The Bcl-2 family regulates the mitochondrial gate, controlling drug-induced apoptosis.
Conclusions:
- Transcription factors are pivotal in promoting apoptosis following anticancer drug treatment by targeting downstream genes, including apoptosis-related ones.
- Identifying specific downstream targets of transcription factors involved in apoptosis is essential.
- Developing effective transcription factor-targeted chemotherapy requires a strategic approach to understanding these molecular players.